文献速递小儿神经外科与脑积水神经重症

静脉与脑室内达托霉素联合静脉利奈唑胺治疗婴儿耐万古霉素肠球菌所致脑室腹腔分流感染

Intravenous and Intraventricular Daptomycin Plus Intravenous Linezolid Treatment of an Infant with Vancomycin-Resistant Enterococci-Induced Ventriculoperitoneal Shunt Infection.
PubMed 文献 · World Neurosurg · 2019-01-24

本文报告一例2.5月龄男婴因耐万古霉素屎肠球菌引起脑室腹腔分流感染,采用静脉利奈唑胺联合静脉及脑室内达托霉素治疗,治疗第5天脑脊液培养转阴,随访8个月无感染复发。

要点

  • 耐万古霉素肠球菌(VRE)引起的中枢神经系统感染罕见,这是首例儿童VRE相关脑室腹腔分流感染报告。
  • 治疗方案为静脉利奈唑胺联合静脉达托霉素(8 mg/kg/天)及脑室内达托霉素(2.5 mg/kg/天)。
  • 治疗第5天脑脊液培养无生长,治疗期间未见副作用,随访8个月无感染。

核心结论

  • 静脉利奈唑胺联合静脉及脑室内达托霉素成功治疗了这例婴儿VRE所致脑室腹腔分流感染,治疗第5天培养转阴,随访8个月无感染。

研究设计与样本

  • 病例报告:1例2.5月龄男婴,因耐万古霉素屎肠球菌引起脑室腹腔分流感染。

主要发现

  • 患者因脐部流液入院,按分流功能障碍行分流管调整术,术后间断脐部脑脊液漏,术后2周发热。
  • 脑脊液培养VRE生长,予美罗培南和利奈唑胺治疗,培养持续阳性后转至作者医院行脑室外引流。
  • 治疗方案为静脉利奈唑胺、静脉达托霉素(8 mg/kg/天)和脑室内达托霉素(2.5 mg/kg/天)。
  • 治疗第5天培养无生长,治疗期间未见副作用。
  • 静脉达托霉素联合脑室内达托霉素治疗15天、利奈唑胺治疗36天后放置脑室腹腔分流管,随访8个月无感染。

关键数值与推荐

  • 静脉达托霉素剂量8 mg/kg/天,脑室内达托霉素剂量2.5 mg/kg/天,利奈唑胺疗程36天。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The rate of ventriculoperitoneal (VP) shunt infection is reported between 3% and 20%. Vancomycin-resistant enterococci (VRE) are increasingly prevalent nosocomial pathogens worldwide, and they rarely cause infections to the central nervous system. Daptomycin is a cyclic lipopeptide effective antibiotic because of its rapid bactericidal effect. It is a life-saving treatment option for meningitis, bacteremia, sepsis, endocarditis, and urinary system infections caused by VRE. CASE DESCRIPTION: Here, we present a 2.5-month-old infant boy with a ventriculoperitoneal shunt infection caused by vancomycin-resistant Enterococcus faecium. This is the first report of a pediatric VP shunt infection caused by VRE and treated with a combination of intravenous (IV) linezolid IV and intraventricular (IVT) daptomycin. CONCLUSION: The patient was admitted to the medical center with umbilical discharge, and shunt revision was applied with the thought of shunt dysfunction. Intermittent umbilical cerebrospinal fluid (CSF) leakage continued, and the patient experienced a fever 2 weeks after the operation. VRE growth in his CSF culture was treated by meropenem and linezolid. Upon continuation of the growth afterwards, the patient was referred to our hospital and underwent extraventricular drainage, and IV linezolid, IV daptomycin (8 mg/kg per day), and IVT daptomycin (2.5 mg/kg per day) was scheduled as treatment. On the fifth day of treatment, there was no growth in the culture, and no side effects were observed during the treatment. A VP shunt was placed in the patient for the 15 days of IV daptomycin plus IVT treatment, and 36 days of linezolid. No infection was observed in the 8-month follow-up period.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Şahin A, Dalgic N. Intravenous and Intraventricular Daptomycin Plus Intravenous Linezolid Treatment of an Infant with Vancomycin-Resistant Enterococci-Induced Ventriculoperitoneal Shunt Infection. World Neurosurg. 2019. PMID: 30685371. doi:10.1016/j.wneu.2019.01.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。